Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberculosis, Multidrug-Resistant | 40 | 2019 | 939 | 2.070 |
Why?
|
Antitubercular Agents | 42 | 2019 | 1391 | 1.690 |
Why?
|
Directly Observed Therapy | 10 | 2012 | 139 | 0.910 |
Why?
|
Peru | 42 | 2019 | 890 | 0.900 |
Why?
|
Tuberculosis, Pulmonary | 14 | 2019 | 846 | 0.830 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 6 | 2017 | 86 | 0.700 |
Why?
|
Mycobacterium tuberculosis | 24 | 2019 | 1929 | 0.670 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2015 | 590 | 0.580 |
Why?
|
Tuberculosis | 15 | 2016 | 2029 | 0.460 |
Why?
|
Social Support | 6 | 2011 | 2191 | 0.440 |
Why?
|
Sputum | 13 | 2019 | 512 | 0.380 |
Why?
|
Contact Tracing | 5 | 2019 | 275 | 0.370 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2011 | 1903 | 0.350 |
Why?
|
Community Health Services | 7 | 2012 | 659 | 0.300 |
Why?
|
HIV Infections | 14 | 2016 | 17575 | 0.260 |
Why?
|
Developing Countries | 10 | 2016 | 2903 | 0.230 |
Why?
|
Health Services | 2 | 2011 | 756 | 0.230 |
Why?
|
Microbial Sensitivity Tests | 13 | 2019 | 1961 | 0.220 |
Why?
|
Preventive Health Services | 1 | 2006 | 568 | 0.190 |
Why?
|
Poverty | 7 | 2016 | 2721 | 0.180 |
Why?
|
Residence Characteristics | 1 | 2010 | 2122 | 0.180 |
Why?
|
Drug Resistance, Multiple | 4 | 2008 | 255 | 0.170 |
Why?
|
Information Systems | 1 | 2002 | 400 | 0.170 |
Why?
|
Medical Records Systems, Computerized | 2 | 2004 | 1196 | 0.160 |
Why?
|
Anti-HIV Agents | 3 | 2011 | 4571 | 0.160 |
Why?
|
Family Characteristics | 4 | 2013 | 1003 | 0.140 |
Why?
|
Pyrazinamide | 2 | 2015 | 60 | 0.140 |
Why?
|
Mental Health | 1 | 2011 | 3276 | 0.130 |
Why?
|
Quality of Health Care | 2 | 2014 | 4339 | 0.120 |
Why?
|
Rifampin | 4 | 2019 | 345 | 0.120 |
Why?
|
Delivery of Health Care | 2 | 2016 | 5375 | 0.120 |
Why?
|
Mycobacterium | 1 | 2015 | 252 | 0.110 |
Why?
|
Entamoebiasis | 1 | 2013 | 12 | 0.110 |
Why?
|
Protozoan Infections | 1 | 2013 | 38 | 0.110 |
Why?
|
Amebiasis | 1 | 2013 | 33 | 0.110 |
Why?
|
Giardiasis | 1 | 2013 | 28 | 0.110 |
Why?
|
Blastocystis Infections | 1 | 2013 | 17 | 0.110 |
Why?
|
Developed Countries | 1 | 2016 | 452 | 0.110 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2014 | 108 | 0.110 |
Why?
|
Urban Population | 3 | 2011 | 2045 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 2 | 2010 | 1063 | 0.100 |
Why?
|
Russia | 4 | 2017 | 386 | 0.100 |
Why?
|
Anthropology, Cultural | 1 | 2010 | 103 | 0.090 |
Why?
|
Adult | 38 | 2019 | 223640 | 0.090 |
Why?
|
National Health Programs | 2 | 2011 | 442 | 0.080 |
Why?
|
Qualitative Research | 2 | 2011 | 3131 | 0.080 |
Why?
|
Antibiotics, Antitubercular | 3 | 2005 | 99 | 0.080 |
Why?
|
Humans | 66 | 2019 | 768393 | 0.080 |
Why?
|
Financial Management | 1 | 2010 | 161 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1255 | 0.080 |
Why?
|
Young Adult | 18 | 2019 | 60049 | 0.080 |
Why?
|
Models, Organizational | 1 | 2011 | 548 | 0.070 |
Why?
|
Treatment Outcome | 20 | 2015 | 65379 | 0.070 |
Why?
|
Verbal Behavior | 1 | 2008 | 336 | 0.070 |
Why?
|
Treatment Failure | 4 | 2016 | 2663 | 0.070 |
Why?
|
Isoniazid | 3 | 2019 | 288 | 0.070 |
Why?
|
Population Surveillance | 4 | 2011 | 2598 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2012 | 962 | 0.070 |
Why?
|
Stereotyping | 1 | 2008 | 242 | 0.070 |
Why?
|
Male | 38 | 2019 | 364902 | 0.070 |
Why?
|
Adolescent | 19 | 2019 | 89184 | 0.070 |
Why?
|
Health Services Needs and Demand | 2 | 2011 | 1407 | 0.070 |
Why?
|
Female | 40 | 2019 | 397089 | 0.070 |
Why?
|
Trust | 1 | 2010 | 532 | 0.060 |
Why?
|
Medical Errors | 1 | 2014 | 1263 | 0.060 |
Why?
|
Drug Therapy, Combination | 7 | 2015 | 6318 | 0.060 |
Why?
|
Food Supply | 1 | 2011 | 544 | 0.060 |
Why?
|
Cohort Studies | 12 | 2016 | 41795 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3579 | 0.060 |
Why?
|
Incidence | 8 | 2019 | 21544 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 432 | 0.060 |
Why?
|
Focus Groups | 1 | 2010 | 1453 | 0.060 |
Why?
|
Government Programs | 1 | 2006 | 278 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2009 | 2185 | 0.060 |
Why?
|
Social Stigma | 1 | 2011 | 785 | 0.060 |
Why?
|
Middle Aged | 20 | 2019 | 223491 | 0.060 |
Why?
|
Retrospective Studies | 19 | 2015 | 81801 | 0.050 |
Why?
|
Medication Systems, Hospital | 1 | 2004 | 154 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 954 | 0.050 |
Why?
|
Community-Institutional Relations | 1 | 2004 | 208 | 0.050 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2005 | 366 | 0.050 |
Why?
|
Social Environment | 1 | 2007 | 1018 | 0.050 |
Why?
|
Mass Screening | 2 | 2011 | 5451 | 0.050 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12558 | 0.050 |
Why?
|
Prospective Studies | 9 | 2019 | 54920 | 0.050 |
Why?
|
Child, Preschool | 8 | 2019 | 42650 | 0.050 |
Why?
|
Information Management | 1 | 2002 | 100 | 0.050 |
Why?
|
Cost of Illness | 1 | 2010 | 1959 | 0.040 |
Why?
|
Prevalence | 6 | 2016 | 15872 | 0.040 |
Why?
|
Latvia | 2 | 2012 | 15 | 0.040 |
Why?
|
Estonia | 2 | 2012 | 56 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4748 | 0.040 |
Why?
|
Philippines | 2 | 2012 | 95 | 0.040 |
Why?
|
Socioeconomic Factors | 5 | 2012 | 7861 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2663 | 0.040 |
Why?
|
Time Factors | 7 | 2013 | 40272 | 0.040 |
Why?
|
Lesotho | 2 | 2011 | 76 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3912 | 0.040 |
Why?
|
Medication Adherence | 1 | 2011 | 2189 | 0.040 |
Why?
|
Endemic Diseases | 1 | 2000 | 190 | 0.040 |
Why?
|
Language | 1 | 2008 | 1558 | 0.040 |
Why?
|
Patient Compliance | 2 | 2006 | 2693 | 0.040 |
Why?
|
Tuberculin Test | 1 | 2019 | 205 | 0.040 |
Why?
|
Emotions | 1 | 2010 | 2768 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 1999 | 198 | 0.040 |
Why?
|
Primary Prevention | 2 | 2010 | 1187 | 0.040 |
Why?
|
Infant | 5 | 2019 | 36510 | 0.040 |
Why?
|
Health Resources | 1 | 2004 | 950 | 0.040 |
Why?
|
Child | 10 | 2019 | 80891 | 0.040 |
Why?
|
Substance-Related Disorders | 2 | 2012 | 4429 | 0.040 |
Why?
|
Clinical Protocols | 3 | 2015 | 1445 | 0.040 |
Why?
|
Drug Administration Schedule | 5 | 2006 | 4859 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4528 | 0.040 |
Why?
|
Medication Errors | 1 | 2004 | 784 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6541 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2004 | 1397 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 716 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1794 | 0.030 |
Why?
|
Risk Factors | 10 | 2017 | 74962 | 0.030 |
Why?
|
Case-Control Studies | 5 | 2014 | 22296 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2002 | 964 | 0.030 |
Why?
|
Asia | 1 | 2017 | 627 | 0.030 |
Why?
|
Research Design | 2 | 2014 | 6210 | 0.030 |
Why?
|
Aged | 10 | 2019 | 171562 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39407 | 0.030 |
Why?
|
Entamoeba | 1 | 2013 | 5 | 0.030 |
Why?
|
Endolimax | 1 | 2013 | 6 | 0.030 |
Why?
|
Blastocystis hominis | 1 | 2013 | 6 | 0.030 |
Why?
|
Giardia lamblia | 1 | 2013 | 23 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5512 | 0.030 |
Why?
|
Sex Distribution | 2 | 2011 | 2281 | 0.030 |
Why?
|
Program Development | 2 | 2011 | 1298 | 0.020 |
Why?
|
South Africa | 1 | 2017 | 1871 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12092 | 0.020 |
Why?
|
Patient Credit and Collection | 1 | 2010 | 16 | 0.020 |
Why?
|
HIV | 2 | 2012 | 1596 | 0.020 |
Why?
|
Program Evaluation | 2 | 2011 | 2505 | 0.020 |
Why?
|
Laboratories | 1 | 2014 | 463 | 0.020 |
Why?
|
Poverty Areas | 1 | 2011 | 269 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2014 | 877 | 0.020 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 223 | 0.020 |
Why?
|
Drug Resistance, Microbial | 2 | 2005 | 830 | 0.020 |
Why?
|
Internet | 1 | 2002 | 3107 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2011 | 426 | 0.020 |
Why?
|
Financing, Personal | 1 | 2011 | 310 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2010 | 283 | 0.020 |
Why?
|
Health Care Costs | 2 | 2011 | 3267 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8379 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2008 | 210 | 0.020 |
Why?
|
Psychology | 1 | 2009 | 355 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2007 | 301 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1476 | 0.020 |
Why?
|
Peer Group | 1 | 2011 | 698 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18471 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2011 | 718 | 0.020 |
Why?
|
Cost Savings | 1 | 2011 | 915 | 0.020 |
Why?
|
Needs Assessment | 1 | 2011 | 1142 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2009 | 664 | 0.020 |
Why?
|
Education | 1 | 2008 | 535 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 26411 | 0.020 |
Why?
|
Ambulatory Care | 2 | 2008 | 2784 | 0.010 |
Why?
|
Streptomycin | 1 | 2004 | 69 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6241 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9636 | 0.010 |
Why?
|
Retreatment | 1 | 2006 | 600 | 0.010 |
Why?
|
Ethambutol | 1 | 2004 | 59 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1515 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2011 | 2740 | 0.010 |
Why?
|
Infection Control | 1 | 2010 | 985 | 0.010 |
Why?
|
Survival Rate | 2 | 2012 | 12870 | 0.010 |
Why?
|
World Health Organization | 2 | 2000 | 1327 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 242 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13646 | 0.010 |
Why?
|
Inservice Training | 1 | 2004 | 375 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6350 | 0.010 |
Why?
|
Health Plan Implementation | 1 | 2004 | 338 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2014 | 3203 | 0.010 |
Why?
|
Community Health Centers | 1 | 2005 | 469 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10776 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3211 | 0.010 |
Why?
|
Mutation | 1 | 2005 | 30228 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7453 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9682 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2529 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2006 | 857 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13323 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8731 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3858 | 0.010 |
Why?
|
Sampling Studies | 1 | 2000 | 616 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2482 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8075 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13042 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2862 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15939 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8506 | 0.010 |
Why?
|
Electromyography | 1 | 2003 | 1402 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 2877 | 0.010 |
Why?
|
Health Planning | 1 | 1998 | 232 | 0.010 |
Why?
|
Risk Assessment | 3 | 2004 | 24318 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8562 | 0.010 |
Why?
|
International Cooperation | 1 | 2003 | 1438 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15455 | 0.010 |
Why?
|
Morals | 1 | 1998 | 288 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3413 | 0.010 |
Why?
|
Boston | 1 | 2007 | 9371 | 0.010 |
Why?
|
Pregnancy | 2 | 2009 | 30200 | 0.010 |
Why?
|
Body Mass Index | 1 | 2012 | 13052 | 0.010 |
Why?
|
Nurses | 1 | 2004 | 2494 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4775 | 0.010 |
Why?
|
HIV-1 | 1 | 2009 | 6963 | 0.010 |
Why?
|
Health Personnel | 1 | 2004 | 3380 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 3707 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59686 | 0.010 |
Why?
|
Health Surveys | 1 | 2000 | 4056 | 0.010 |
Why?
|
Disease Management | 1 | 1999 | 2537 | 0.000 |
Why?
|
Mental Disorders | 1 | 2008 | 6876 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5538 | 0.000 |
Why?
|
Animals | 1 | 2009 | 169337 | 0.000 |
Why?
|